Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
BeOne Medicines
Ipsen
BeiGene
Hoffmann-La Roche
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Celgene
Ipsen
City of Hope Medical Center
Gilead Sciences
CytomX Therapeutics
National Cancer Institute (NCI)
Hackensack Meridian Health
TCR2 Therapeutics
Atara Biotherapeutics
Celgene
Columbia University
New York Medical College
Fred Hutchinson Cancer Center
Pharmacyclics LLC.
Spectrum Pharmaceuticals, Inc
Gilead Sciences
City of Hope Medical Center
St. Petersburg State Pavlov Medical University
Hoffmann-La Roche
Mayo Clinic
Chinese PLA General Hospital
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Acrotech Biopharma Inc.
Mayo Clinic
Swiss Cancer Institute
University of Washington
Lymphoma Study Association
Takeda
Lund University Hospital
National Institutes of Health Clinical Center (CC)
Idera Pharmaceuticals, Inc.
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Washington
Weill Medical College of Cornell University